DHB Stock Overview Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Add noteDelivra Health Brands Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Delivra Health Brands Historical stock prices Current Share Price CA$0.015 52 Week High CA$0.055 52 Week Low CA$0.015 Beta 1.05 1 Month Change -25.00% 3 Month Change -25.00% 1 Year Change -25.00% 3 Year Change -76.92% 5 Year Change -92.11% Change since IPO -97.92%
Recent News & Updates
New major risk - Revenue and earnings growth Dec 06
First quarter 2025 earnings released: CA$0.002 loss per share (vs CA$0.001 profit in 1Q 2024) Nov 26
New major risk - Revenue and earnings growth Nov 11
Delivra Health Brands Inc., Annual General Meeting, Dec 18, 2024 Oct 29
Full year 2024 earnings: EPS exceeds analyst expectations Oct 08
New minor risk - Profitability May 28 See more updates
New major risk - Revenue and earnings growth Dec 06
First quarter 2025 earnings released: CA$0.002 loss per share (vs CA$0.001 profit in 1Q 2024) Nov 26
New major risk - Revenue and earnings growth Nov 11
Delivra Health Brands Inc., Annual General Meeting, Dec 18, 2024 Oct 29
Full year 2024 earnings: EPS exceeds analyst expectations Oct 08
New minor risk - Profitability May 28
Third quarter 2024 earnings released: CA$0.001 loss per share (vs CA$0.003 loss in 3Q 2023) May 17
Second quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.004 profit in 2Q 2023) Feb 28
Delivra Health Brands Inc., Annual General Meeting, Apr 29, 2024 Feb 17
New minor risk - Shareholder dilution Dec 19 Delivra Health Brands Inc. announced that it has received CAD 0.9 million in funding Dec 13
Delivra Health Brands Inc. announced that it expects to receive CAD 0.9 million in funding Dec 02 Delivra Health Brands Inc. announced that it expects to receive CAD 0.9 million in funding Dec 01
First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.002 loss in 1Q 2023) Nov 29
Insufficient new directors Nov 01
Full year 2023 earnings released: CA$0.001 loss per share (vs CA$0.028 loss in FY 2022) Oct 20
Delivra Health Brands Inc. to Report Fiscal Year 2023 Results on Oct 18, 2023 Oct 14
Third quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.007 loss in 3Q 2022) May 26
Delivra Health Brands Inc. to Report Q3, 2023 Results on May 23, 2023 May 19
Second quarter 2023 earnings released: EPS: CA$0.004 (vs CA$0.006 loss in 2Q 2022) Feb 22
First quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.006 loss in 1Q 2022) Nov 29
Full year 2022 earnings released: CA$0.028 loss per share (vs CA$0.09 loss in FY 2021) Oct 29
Delivra Health Brands Inc. to Report Fiscal Year 2022 Results on Oct 28, 2022 Oct 26
Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.005 loss in 3Q 2021) Jun 01
Harvest One Cannabis Inc. Provides Earnings Guidance for the Fourth Quarter of 2022 May 31
Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Mar 04
Harvest One Continues to Expand its Licensed LivRelief InfusedTM Product Line with the Listing of Extra Strength Transdermal CBD Cream at the OCS Feb 04
First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat Dec 01
Full year 2021 earnings released: CA$0.13 loss per share (vs CA$0.28 loss in FY 2020) Oct 30
Health Check: How Prudently Does Harvest One Cannabis (CVE:HVT) Use Debt? May 29
Third quarter 2021 earnings released: CA$0.005 loss per share (vs CA$0.17 loss in 3Q 2020) May 29
Harvest One Cannabis Inc. Announces the Launch of Its New LivRelief May 14
Harvest One Cannabis Inc. has completed a Composite Units Offering in the amount of CAD 4.99999 million. Mar 18
Cann Group Limited (ASX:CAN) completed the acquisition of Satipharm Ltd, Satipharm AG and Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT) Mar 11
Second quarter 2021 earnings released Mar 03 Cann Group Limited (ASX:CAN) entered into a definitive sale agreement to acquire Phytotech Therapeutics Ltd from Harvest One Cannabis Inc. (TSXV:HVT).
Cann Group Limited (ASX:CAN) signed a share sale agreement to acquire Satipharm Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for CAD 4 million. Feb 16
Harvest One Continues International Expansion with Asian Distribution Agreement for Dream Water Products Feb 11
Did The Underlying Business Drive Harvest One Cannabis' (CVE:HVT) Lovely 345% Share Price Gain? Feb 11
New 90-day high: CA$0.24 Feb 10
Harvest One Cannabis Inc. Expands Distribution of Dream Water Products in the United States and Internationally Dec 18
Harvest One Cannabis Inc. Announces Executive Changes Dec 02
Full year earnings released - CA$0.29 loss per share Oct 30
An unknown buyer acquired a majority stake in Greenbelt Greenhouse Ltd from Harvest One Cannabis Inc. (TSXV:HVT) for approximately CAD 2.9 million. Oct 18 Harvest One Cannabis Inc. Announces Management Changes Shareholder Returns DHB CA Pharmaceuticals CA Market 7D 0% -0.5% -2.6% 1Y -25.0% -26.7% 15.2%
See full shareholder returns
Return vs Market: DHB underperformed the Canadian Market which returned 15.2% over the past year.
Price Volatility Is DHB's price volatile compared to industry and market? DHB volatility DHB Average Weekly Movement 21.7% Pharmaceuticals Industry Average Movement 12.0% Market Average Movement 8.2% 10% most volatile stocks in CA Market 17.4% 10% least volatile stocks in CA Market 2.9%
Stable Share Price: DHB's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: DHB's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company Delivra Health Brands Inc., through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. The company offers cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It sells its products under LivRelief, Dream Water, and LivRelief infused brands.
Show more Delivra Health Brands Inc. Fundamentals Summary How do Delivra Health Brands's earnings and revenue compare to its market cap? DHB fundamental statistics Market cap CA$4.69m Earnings (TTM ) CA$172.00k Revenue (TTM ) CA$11.87m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) DHB income statement (TTM ) Revenue CA$11.87m Cost of Revenue CA$5.80m Gross Profit CA$6.08m Other Expenses CA$5.90m Earnings CA$172.00k
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.00055 Gross Margin 51.18% Net Profit Margin 1.45% Debt/Equity Ratio 44.3%
How did DHB perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 05:13 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Delivra Health Brands Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Siddharth Rajeev Fundamental Research Corp. Neal Gilmer Haywood Securities Inc. Greg McLeish Research Capital Corporation
Show 0 more analysts